How to Evaluate and Reduce Micro- and/or Macrovascular Residual Risk?

View at publisher
Authors: Michel Paul Hermans, Fabian O. Lurquin, Sylvie A. Ahn, Michel F. Rousseau, on behalf of the Residual Risk Reduction Initiative (R3i)
Cited by: 0
References: 40

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Diabetes Cardiovascular Risks and Lipoproteins Lipid metabolism and disorders

Publication details

Journal / source
Springer eBooks
Pages
263–281
Publication date
1 January 2026
Language
EN
Document type
Book chapter